Comment
Jordan Smith´s article

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

Category: Computers
Submitted by Jordan Smith
26 day(s) ago (Server time: 24.09.2020 09:04:34)

The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are being investigated both as monotherapies and in combination with various immune checkpoint inhibitors, such as atezolizumab, durvalumab, ipilimumab, and nivolumab. Of these, certain pipeline candidates have already entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.

 

To order this 320+ page report, which features 110+ figures and 140+ tables, please visit this link  

 

The USD 3 billion (by 2030) financial opportunity within the neoantigens market has been analyzed across the following segments:

 

 

 

 

 

The report features inputs from eminent industry stakeholders, according to whom neoantigen targeted therapies are expected to be the next big step in cancer immunotherapy. Similar to CAR-T cell therapies, these therapies have, so far, demonstrated significant therapeutic potential and promising clinical outcomes. The report includes detailed transcripts of discussions held with the following experts:

 

The Neoantigen Targeted Therapies, 2019-2030 report features the following companies, which we identified to be key players in this domain:

Press Release: Variation 3 (Format 4)

 

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction

 

  1. Market Overview

  2. Company Profiles: Neoantigen Targeted Therapies

  3. Publication Analysis

  4. Patent Analysis

  5. Partnerships and Collaborations

  6. Funding and Investment Analysis

  7. Market Forecast and Opportunity Analysis

  8. Concluding Remarks

  9. Executive Insights

  10. Appendix 1: Tabulated Data

  11. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html

 

Contact Details:

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Tags:

Comments so far

You could also like

Complete details about SBCGlobal Email Account?
Recover Gmail Account from iPhone
Why It’s Worth Buying a Used Mac Pro
What Makes Industrial Control Panel So Advantageous?
How to Buy a Used MacBook Affordably Online